{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:38:53Z","timestamp":1753882733981,"version":"3.41.2"},"reference-count":51,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Gates Ventures","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2022,5,18]]},"abstract":"<jats:p>Home testing for infectious disease has come to the forefront during the COVID-19 pandemic. There is now considerable commercial interest in developing complete home tests for a variety of viral and bacterial pathogens.<\/jats:p>","DOI":"10.1128\/jcm.01884-21","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T01:46:02Z","timestamp":1639619162000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":3,"title":["Requirements and Study Designs for U.S. Regulatory Approval of Influenza Home Tests"],"prefix":"10.1128","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0046-4492","authenticated-orcid":true,"given":"Tony","family":"Yang","sequence":"first","affiliation":[{"name":"Biomedical Regulatory Affairs Program, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8024-5424","authenticated-orcid":true,"given":"Larry G.","family":"Kessler","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Washington, Seattle, Washington, USA"},{"name":"Department of Pharmacy, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Washington, Seattle, Washington, USA"},{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4298-4901","authenticated-orcid":true,"given":"Barry R.","family":"Lutz","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, University of Washington, Seattle, Washington, USA"},{"name":"Brotman Baty Institute for Precision Medicine, University of Washington, Seattle, Washington, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"Washington State Clinical Laboratory Advisory Council. 2017. Point-of-care testing guidelines. Washington State Department of Health Olympia WA. https:\/\/www.doh.wa.gov\/portals\/1\/Documents\/2700\/POCT.pdf."},{"key":"e_1_3_2_3_2","unstructured":"Food and Drug Administration Center for Devices and Radiological Health. 2014. Guidance for industry: design considerations for devices intended for home use. https:\/\/www.fda.gov\/media\/84830\/download."},{"key":"e_1_3_2_4_2","unstructured":"Food and Drug Administration. Home use tests. https:\/\/www.fda.gov\/medical-devices\/vitro-diagnostics\/home-use-tests. Accessed January 2021."},{"key":"e_1_3_2_5_2","unstructured":"Conenello G. 2016. Microbiology devices panel meeting: over-the-counter diagnostic tests for the detection of pathogens causing infectious diseases. https:\/\/www.fda.gov\/media\/99903\/download."},{"key":"e_1_3_2_6_2","unstructured":"Food and Drug Administration Center for Devices and Radiological Health. 2020. Guidance for industry: policy for Coronavirus disease-2019 tests during the public health emergency (revised). https:\/\/www.fda.gov\/media\/135659\/download."},{"key":"e_1_3_2_7_2","unstructured":"Food and Drug Administration. Template for developers of molecular and antigen diagnostic COVID-19 tests for home use. https:\/\/www.fda.gov\/media\/140615\/download. Accessed November 2021."},{"key":"e_1_3_2_8_2","unstructured":"Centers for Disease Control and Prevention. Key facts about influenza (flu). https:\/\/www.cdc.gov\/flu\/about\/keyfacts.htm. Accessed January 2021."},{"key":"e_1_3_2_9_2","unstructured":"WebMD. What are your odds of getting the flu? https:\/\/www.webmd.com\/cold-and-flu\/flu-statistics. Accessed January 2021."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00791-15"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12820"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2019.07.010"},{"key":"e_1_3_2_13_2","unstructured":"Food and Drug Administration. 2006. Blood Products Advisory Committee 86th meeting session on proposed studies to support the approval of over-the-counter (OTC) home use HIV test kits. https:\/\/wayback.archive-it.org\/7993\/20170405061033\/https:\/\/www.fda.gov\/ohrms\/dockets\/ac\/06\/briefing\/2006-4206B2_1.pdf."},{"key":"e_1_3_2_14_2","unstructured":"Food and Drug Administration. Classify your medical device. https:\/\/www.fda.gov\/medical-devices\/overview-device-regulation\/classify-your-medical-device. Accessed January 2021."},{"key":"e_1_3_2_15_2","unstructured":"Food and Drug Administration. Overview of medical device classification and reclassification. https:\/\/www.fda.gov\/about-fda\/cdrh-transparency\/overview-medical-device-classification-and-reclassification. Accessed January 2021."},{"key":"e_1_3_2_16_2","unstructured":"Food and Drug Administration. Product classification database. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfPCD\/PCDSimpleSearch.cfm. Accessed October 2021."},{"key":"e_1_3_2_17_2","unstructured":"Food and Drug Administration. De novo classification request. https:\/\/www.fda.gov\/medical-devices\/premarket-submissions\/de-novo-classification-request. Accessed October 2021."},{"key":"e_1_3_2_18_2","unstructured":"Food and Drug Administration. In vitro diagnostics EUAs. https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/vitro-diagnostics-euas. Accessed January 2021."},{"key":"e_1_3_2_19_2","unstructured":"Centers for Disease Control and Prevention. Waived tests. https:\/\/www.cdc.gov\/labquality\/waived-tests.html. Accessed January 2021."},{"key":"e_1_3_2_20_2","unstructured":"Food and Drug Administration Center for Devices and Radiological Health. 2020. Guidance for industry: recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver applications for manufacturers of in vitro diagnostic devices. https:\/\/www.fda.gov\/media\/109582\/download."},{"key":"e_1_3_2_21_2","unstructured":"Food and Drug Administration Center for Devices and Radiological Health. 2011. Guidance for industry: establishing the performance characteristics of in vitro diagnostic devices for the detection or detection and differentiation of influenza viruses. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/establishing-performance-characteristics-vitro-diagnostic-devices-detection-or-detection-and. Accessed January 2021."},{"key":"e_1_3_2_22_2","unstructured":"Food and Drug Administration Center for Devices and Radiological Health. 2016. Guidance for industry: applying human factors and usability engineering to medical devices. https:\/\/www.fda.gov\/media\/80481\/download."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz360.1638"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2019-208446"},{"key":"e_1_3_2_25_2","unstructured":"Centers for Disease Control and Prevention. Guide for considering influenza testing when influenza viruses are circulating in the community. https:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/consider-influenza-testing.htm. Accessed January 2021."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-7-75"},{"key":"e_1_3_2_27_2","unstructured":"World Health Organization. 2005. WHO recommendations on the use of rapid testing for influenza diagnosis. https:\/\/www.who.int\/influenza\/resources\/documents\/RapidTestInfluenza_WebVersion.pdf."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.12.006"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy866"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105786"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12309"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.02.011"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239000"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piy136"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-7-85"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02934-20"},{"key":"e_1_3_2_37_2","unstructured":"ClinicalTrials.gov. Home testing of respiratory illness. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04245800. Accessed January 2021."},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","unstructured":"Heimonen J McCulloch DJ O\u2019Hanlon J Kim AE Emanuels A Wilcox N Brandstetter E Stewart M McCune D Fry S Parsons S Hughes JP Jackson JL Uyeki TM Boeckh M Starita LM Bedford T Englund JA Chu HY. 2021. A remote household-based approach to influenza self-testing and antiviral treatment. MedRxiv https:\/\/www.medrxiv.org\/content\/10.1101\/2021.02.01.21250973v1.","DOI":"10.1101\/2021.02.01.21250973"},{"key":"e_1_3_2_39_2","unstructured":"Food and Drug Administration. 2014. 510(k) Substantial equivalence determination decision summary K141520. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/K141520.pdf."},{"key":"e_1_3_2_40_2","unstructured":"Food and Drug Administration. FDA strategic plan for risk communication and health literacy 2017\u20132019. https:\/\/www.fda.gov\/media\/108318\/download. Accessed October 2021."},{"key":"e_1_3_2_41_2","unstructured":"Food and Drug Administration Center for Devices and Radiological Health. 2009. Guidance for industry: testing for detection and differentiation of influenza A virus subtypes using multiplex assays\u2014class II special controls. https:\/\/www.fda.gov\/medical-devices\/guidance-documents-medical-devices-and-radiation-emitting-products\/testing-detection-and-differentiation-influenza-virus-subtypes-using-multiplex-assays-class-ii. Accessed January 2021."},{"key":"e_1_3_2_42_2","unstructured":"International Organization for Standardization. 2019. ISO 14971:2019(E). Medical devices\u2014application of risk management to medical devices. https:\/\/www.iso.org\/standard\/72704.html."},{"key":"e_1_3_2_43_2","unstructured":"Food and Drug Administration. CLIA waiver by application decision summaries. https:\/\/www.fda.gov\/about-fda\/cdrh-transparency\/clia-waiver-application-decision-summaries. Accessed November 2021."},{"key":"e_1_3_2_44_2","unstructured":"Food and Drug Administration. Template for developers of molecular diagnostic tests. https:\/\/www.fda.gov\/media\/135900\/download. Accessed October 2021."},{"key":"e_1_3_2_45_2","unstructured":"Food and Drug Administration Center for Drug Evaluation and Research. 2013. Guidance for industry: self-selection studies for nonprescription drug products. https:\/\/www.fda.gov\/media\/81141\/download."},{"key":"e_1_3_2_46_2","unstructured":"Food and Drug Administration Center for Devices and Radiological Health. 2006. Guidance for industry: class II special controls guidance document: reagents for detection of specific novel influenza A viruses. https:\/\/www.fda.gov\/media\/71140\/download."},{"key":"e_1_3_2_47_2","unstructured":"Food and Drug Administration. Manufacturer and user facility device experience database\u2014(MAUDE). https:\/\/www.fda.gov\/medical-devices\/mandatory-reporting-requirements-manufacturers-importers-and-device-user-facilities\/manufacturer-and-user-facility-device-experience-database-maude. Accessed January 2021."},{"key":"e_1_3_2_48_2","first-page":"97","article-title":"FDA flags inconsistent hospital reporting of medical device problems: hazy reporting rules beget confusion","volume":"42","author":"Barlas S","year":"2017","unstructured":"Barlas S. 2017. FDA flags inconsistent hospital reporting of medical device problems: hazy reporting rules beget confusion. P T 42:97\u2013115.","journal-title":"P T"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.6.857"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-036298"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.2196\/28268"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.02070-21"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.01884-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.01884-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T13:03:24Z","timestamp":1652879004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.01884-21"}},"subtitle":[],"editor":[{"given":"Romney M.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,18]]}},"alternative-id":["10.1128\/jcm.01884-21"],"URL":"https:\/\/doi.org\/10.1128\/jcm.01884-21","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"type":"print","value":"0095-1137"},{"type":"electronic","value":"1098-660X"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"2022-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01884-21"}}